相似文献
1
Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada.
Antimicrob Agents Chemother. 1999 Sep;43(9):2144-7. doi: 10.1128/AAC.43.9.2144.
2
Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.
Antimicrob Agents Chemother. 1999 Aug;43(8):1935-40. doi: 10.1128/AAC.43.8.1935.
3
Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan.
J Clin Microbiol. 2000 Jul;38(7):2475-9. doi: 10.1128/JCM.38.7.2475-2479.2000.
4
Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates.
J Antimicrob Chemother. 2000 Feb;45(2):167-73. doi: 10.1093/jac/45.2.167.
5
Erythromycin resistance genes in Streptococcus pyogenes isolates in Kanagawa, Japan.
Microbiol Immunol. 2000;44(10):863-5. doi: 10.1111/j.1348-0421.2000.tb02575.x.
6
Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance.
Antimicrob Agents Chemother. 1999 Jan;43(1):48-52. doi: 10.1128/AAC.43.1.48.
7
Erythromycin-resistant genes in group A β-haemolytic Streptococci in Chengdu, Southwestern China.
Indian J Med Microbiol. 2014 Jul-Sep;32(3):290-3. doi: 10.4103/0255-0857.136568.
8
Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.
Eur J Clin Microbiol Infect Dis. 1998 Jan;17(1):25-31. doi: 10.1007/BF01584359.
9
Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California.
J Clin Microbiol. 1999 Jun;37(6):1727-31. doi: 10.1128/JCM.37.6.1727-1731.1999.
10
Macrolide-resistant genes of Streptococcus pyogenes isolated from the upper respiratory tract by polymerase chain reaction.
J Infect Chemother. 2004 Apr;10(2):115-20. doi: 10.1007/s10156-004-0302-x.
引用本文的文献
1
Serotype Distribution and Antimicrobial Resistance of Streptococcus agalactiae Isolates in Nonpregnant Adults with Streptococcal Toxic Shock Syndrome in Japan in 2014 to 2021.
Microbiol Spectr. 2023 Feb 14;11(2):e0498722. doi: 10.1128/spectrum.04987-22.
2
emm Types and clusters and macrolide resistance of pediatric group A streptococcal isolates in Central Greece during 2011-2017.
PLoS One. 2020 May 7;15(5):e0232777. doi: 10.1371/journal.pone.0232777. eCollection 2020.
3
Survey of strain distribution and antibiotic resistance pattern of group B streptococci (Streptococcus agalactiae) isolated from clinical specimens.
GMS Hyg Infect Control. 2016 Sep 12;11:Doc18. doi: 10.3205/dgkh000278. eCollection 2016.
4
Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012.
Epidemiol Infect. 2015 Mar;143(4):864-72. doi: 10.1017/S0950268814001265.
5
Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.
Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1155-62. doi: 10.1007/s10096-014-2055-5. Epub 2014 Jan 28.
6
In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae.
Antimicrob Agents Chemother. 2014;58(3):1693-8. doi: 10.1128/AAC.02210-13. Epub 2013 Dec 30.
7
Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy.
Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1741-7. doi: 10.1007/s10096-011-1495-4. Epub 2011 Nov 26.
8
Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil.
J Clin Microbiol. 2010 Dec;48(12):4397-403. doi: 10.1128/JCM.00419-10. Epub 2010 Sep 29.
9
Antistreptococcal activity of AR-709 compared to that of other agents.
Antimicrob Agents Chemother. 2008 Jun;52(6):2279-82. doi: 10.1128/AAC.01620-07. Epub 2008 Mar 24.
10
Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004.
J Clin Microbiol. 2008 Jan;46(1):79-86. doi: 10.1128/JCM.01626-07. Epub 2007 Oct 24.
本文引用的文献
1
The Serological Classification of Streptococcus pyogenes.
J Hyg (Lond). 1934 Dec;34(4):542-84. doi: 10.1017/s0022172400043308.
2
Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance.
Antimicrob Agents Chemother. 1999 Jan;43(1):48-52. doi: 10.1128/AAC.43.1.48.
3
Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae.
Antimicrob Agents Chemother. 1998 Sep;42(9):2425-6. doi: 10.1128/AAC.42.9.2425.
4
Why have group A streptococci remained susceptible to penicillin? Report on a symposium.
Clin Infect Dis. 1998 Jun;26(6):1341-5. doi: 10.1086/516375.
5
Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa.
Emerg Infect Dis. 1998 Apr-Jun;4(2):277-81. doi: 10.3201/eid0402.980216.
6
A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes.
Antimicrob Agents Chemother. 1998 Feb;42(2):257-62. doi: 10.1128/AAC.42.2.257.
7
Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.
Eur J Clin Microbiol Infect Dis. 1998 Jan;17(1):25-31. doi: 10.1007/BF01584359.
8
Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes.
J Antimicrob Chemother. 1998 Jan;41(1):135-7. doi: 10.1093/jac/41.1.135.
9
Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance.
J Infect Dis. 1998 Mar;177(3):786-9. doi: 10.1086/517809.
10
High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study.
Microb Drug Resist. 1997 Winter;3(4):371-8. doi: 10.1089/mdr.1997.3.371.
Zotero 插件